Latest clinical and technology update of Firehawk Target eluting stent platform

Sponsored by MicroPort

Chairpersons: M. Leon, W. Wijns
Panellists: A. Baumbach, A. Lansky
SHOW MORE

Summary

Consult this session to discover all about the latest clinical and technology update of Firehawk Target eluting stent platform, the results and insights of Target AC trial 2-year follow-up, and more!

Learning Objectives

  • To understand the results and insights of Target AC trial 2-year follow-up results
  • To understand the Compare Crush Trial protocol
  • To learn the first hand clinical experience with next-gen Firehawk platform

Presentations available when logged in:

  • Target AC 2-year follow up results
  • Introduction to COMPARE CRUSH - A STEMI pre-treatment trial using the MicroPort Firehawk stent
  • Firehawk clinical experience with complex lesions
  • Session evaluation and key learnings